Differences in bone quality in low- and high-turnover renal osteodystrophy
about
Bone composition: relationship to bone fragility and antiosteoporotic drug effectsCan one evaluate bone disease in chronic kidney disease without a biopsy?Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.Changes in skeletal collagen cross-links and matrix hydration in high- and low-turnover chronic kidney disease.Evaluating bone quality in patients with chronic kidney disease.Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case reportCortical bone mechanical properties are altered in an animal model of progressive chronic kidney disease.Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventionsOnly minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone qualityCortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture.The kidney sodium-phosphate co-transporter alters bone quality in an age and gender specific manner.Raloxifene improves skeletal properties in an animal model of cystic chronic kidney diseaseExamining the Relationships Between Bone Tissue Composition, Compositional Heterogeneity, and Fragility Fracture: A Matched Case-Controlled FTIRI Study.Bone Parameters and Risk of Hip and Femur Fractures in Patients on Hemodialysis.Low-energy fractures without low T-scores characteristic of osteoporosis: a possible bone matrix disorderThe Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients.What is the role of bone biopsy in the management of adult dialysis patients?Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway.What Animal Models Have Taught Us About the Safety and Efficacy of Bisphosphonates in Chronic Kidney Disease.Vibrational spectroscopic techniques to assess bone quality.Biomarkers Predicting Bone Turnover in the Setting of CKD.Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates.Cinacalcet: the chemical parathyroidectomy?Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study.Histomorphometric diagnostics of renal osteopathy in chronic dialysis patients at high risk of cardiovascular disease.We Use Too Much Vitamin D in Hemodialysis Patients.Altered Bone Mechanics, Architecture and Composition in the Skeleton of TIMP-3-Deficient Mice.Update on the role of bone biopsy in the management of patients with CKD-MBD.Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes.A multiscale mechanobiological model of bone remodelling predicts site-specific bone loss in the femur during osteoporosis and mechanical disuse.Raman Spectroscopic and Microscopic Analysis for Monitoring Renal Osteodystrophy Signatures.Intrinsic material property differences in bone tissue from patients suffering low-trauma osteoporotic fractures, compared to matched non-fracturing women.Rethinking Bone Disease in Kidney Disease
P2860
Q26863596-EA4CC1CA-D19A-48D0-ACB4-F582DE34C793Q26997002-0E79DE4E-8A0E-4286-93EB-410D6FF88AD3Q30234751-2508222F-1E5A-464C-A972-AB1A4CAEA197Q30873913-EBFB5094-18AC-46E8-B296-B39488A60314Q33602332-35D88868-9E98-4442-A8BE-F7EABF8A035CQ33607092-C9E27E73-4318-49CB-B518-16C50C28739BQ33727902-AF4AE105-6061-4DC5-ABE5-2F8AE5C4E403Q35661168-18BDBB97-C283-4BF5-93D5-4AB20F6D5EE6Q36104700-17EA70FF-DD69-40E2-8250-588966474B68Q36199520-C466FD9E-5ED8-4A06-9E28-22CD29DC2032Q36281399-A01F4DCE-6605-47F7-988B-35538C2E2860Q36672678-0D7DE2D0-2551-424D-9B39-8AC217770FF3Q36823369-B672757E-5728-4C6A-B1C0-5CF5CCAD011EQ36889362-80C82617-EEEA-47E0-B9A8-5E6683F604CEQ36965098-20A00D3B-24E5-4555-8136-6D42237EE385Q37190013-E0BECBAB-5428-4C9A-B1D0-C0A6423C5395Q37670856-82A47571-5B37-4641-BECF-F2537E779D9EQ38200705-F3617DE1-FB98-4398-8544-F569EAFA66F8Q38605457-1F0092B6-AB16-4C76-A86F-9D11CD5AFB28Q38825566-4DA8E0EB-BE92-47AC-B350-C49A0FB697CAQ39220959-8E75E8C8-9921-466B-A4B2-0379C30CC981Q39254025-4A12B227-FBB5-4BE9-AC19-9AC2D54D97A2Q39569410-9433EAC6-A227-445D-8FDF-3312A689A0C0Q39719456-1004F23D-FFCB-41E9-8CBF-9D7B39E96E3DQ41625862-21A2D9A8-DA84-4B2D-89B6-D567EBE3AE60Q43820704-E4298A90-3114-4863-A2C2-A4342EA43A4FQ48058296-07CA183A-E560-4F4E-9220-9EE03E8823F8Q48195251-B7644B20-DF9B-4FD0-8873-2010DDB34C9DQ48197934-C2AF61EE-66A2-4D7E-8B5A-28308CFADC59Q49166621-F6B9BF9C-FDAD-4AC4-9091-7D775419C395Q50871829-CB0A9DF9-0207-40E3-9114-ABC4E07CD5A8Q52593648-699E46B9-BBE1-4F22-94F8-F8364B71CB15Q53752406-2E457A2F-95F1-4773-B29C-50EC49FC19B6Q59126536-A0300B4D-0E3C-4797-AE18-B1DE4ACDA23B
P2860
Differences in bone quality in low- and high-turnover renal osteodystrophy
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Differences in bone quality in low- and high-turnover renal osteodystrophy
@ast
Differences in bone quality in low- and high-turnover renal osteodystrophy
@en
type
label
Differences in bone quality in low- and high-turnover renal osteodystrophy
@ast
Differences in bone quality in low- and high-turnover renal osteodystrophy
@en
prefLabel
Differences in bone quality in low- and high-turnover renal osteodystrophy
@ast
Differences in bone quality in low- and high-turnover renal osteodystrophy
@en
P2093
P2860
P356
P1476
Differences in bone quality in low- and high-turnover renal osteodystrophy
@en
P2093
Daniel S Porter
David Pienkowski
Hanna Mawad
Hartmut H Malluche
Marie-Claude Monier-Faugere
P2860
P304
P356
10.1681/ASN.2010121253
P577
2011-12-22T00:00:00Z